Can Transcranial Magnetic Stimulation Safely Aid Women with Major Depression in Pregnancy?
BACKGROUND AND PURPOSE:
Transcranial magnetic stimulation (TMS) is used by psychiatric patients who do not want or can’t tolerate medications for the treatment of major depressive disorder (MDD)
MDD is common in pregnancy (10%)
Kim et al. (Brain Stimulation., 2018) assessed the efficacy and safety of TMS to treat pregnant women with MDD
Randomized controlled trial (RCT)
Included women with MDD in the second or third trimester
Subjects were randomized to the following arms
20 sessions of TMS to the right dorsolateral prefrontal cortex
1 Hz as a single train of 900 pulses per session at 100% motor threshold
Estradiol and progesterone were measured before session 1 and after session 2
Response: at least a 50% decrease from baseline Hamilton Depression Rating Scale (HDRS-17) score
Remission: HDRS-17 score <8 and a Clinical Global Impression Scale-Severity (CGI-S) score ≤1
22 women were included in the study
The active TMS group exhibited significantly reduced Hamilton Depression Rating Scale (HDRS-17) (p=0.003)
Response rates (p=0.088)
81.82% for the active TMS
45.45% for the sham coil
Remission rates (p=0.613)
27.27% for the active
18.18% for the sham coil
Late preterm birth (PTB) occurred in three women receiving active TMS
35.3, 36.3 and 35.2 weeks
All other maternal and delivery outcomes were normal
Right-sided, low frequency TMS effectively reducing depressive symptoms in this sample based on the Hamilton scale, but was not significant with respect to response and remission rates as defined by this study
Left-sided TMS is becoming standard of care
TMS May be associated with late PTB although a larger sample size would be needed
Sample size not sufficiently large to determine if this finding is significant (would need 33 women in each arm)
Please log in to access ObGFirst and the 2T US Atlas
Media - Internet
Computer System Requirements
OBG Project CME requires a modern web browser (Internet Explorer 10+, Mozilla Firefox, Apple Safari, Google Chrome, Microsoft Edge). Certain educational activities may require additional software to view multimedia, presentation, or printable versions of their content. These activities will be marked as such and will provide links to the required software. That software may be: Adobe Flash, Apple QuickTime, Adobe Acrobat, Microsoft PowerPoint, Windows Media Player, or Real Networks Real One Player.
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information
presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
Jointly provided by
NOT ENOUGH CME HOURS
It appears you don't have enough CME Hours to take this Post-Test. Feel free to buy additional CME hours or upgrade your current CME subscription plan